NIH-funded research R01 grant

Understanding how Cryptococcus spores develop and cause disease

Official title: Maturation, Germination, and Pathogenesis of Cryptococcus Spores

Funded at University of Wisconsin-Madison · NIH-11124113 · Data updated 2026-11-12

This study is looking at how a type of yeast called Cryptococcus grows and spreads in the body, especially in people with weakened immune systems, to find new ways to treat infections and help patients feel better.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Wisconsin-Madison
NIH-funded
Lab location1 site (Madison, United States)
Project startJuly 1, 2024
Project endMay 31, 2029
Funding year2025
Award (this year)$614,385
NIH project number5R01AI179964-02
Project IDNIH-11124113 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with compromised immune systems, such as those living with AIDS, undergoing chemotherapy, or who have received organ transplants.

Less likely to help

Patients with healthy immune systems and no risk factors for fungal infections are unlikely to benefit from this research.

What this research studies

This research investigates the life cycle of Cryptococcus, a yeast that can cause serious infections, particularly in individuals with weakened immune systems. The team aims to uncover how these spores survive and grow in the lungs and potentially spread to the brain, leading to severe health complications. By studying the biology of these spores, the researchers hope to identify new targets for antifungal treatments that could improve patient outcomes. The approach includes analyzing gene expression and the biological mechanisms that allow these fungi to thrive in hostile environments.

Why it matters

Potential benefit: If successful, this research could lead to the development of more effective antifungal therapies for patients at high risk of severe fungal infections.

How similar studies have gone: Previous research has shown promise in understanding fungal pathogens and developing antifungal treatments, indicating that this approach has potential for success.

Where this research is happening

  • University of Wisconsin-Madison
    Madison, United States
    Active

Researchers

  • Principal investigator: Hull, Christina M — University of Wisconsin-Madison
  • Study coordinator: Hull, Christina M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.